Form 4: Medifast Director Jeffrey Brown Increases Stake Through Compensation-Related Stock Acquisitions

Medifast, Inc. Director Jeffrey J. Brown acquired over 20,000 shares of common stock on June 25, 2025, through restricted stock unit grants and an election to receive shares in lieu of cash compensation.

Summary

• Jeffrey J. Brown, a Director of Medifast, Inc. (MED), acquired a total of 20,617.00 shares of common stock on June 25, 2025.
• This acquisition included 11,167.542 restricted stock units (RSUs) granted under the Medifast, Inc. Director's Deferred Compensation Plan, which will vest in full on June 25, 2026.
• An additional 9,449.458 shares were acquired as the reporting person elected to receive common stock in lieu of cash compensation for annual service as a non-employee director.
• The price per share for the 9,449.458 shares was $13.39, based on the 20-day moving average stock price as of June 6, 2025.
• Following these transactions, Mr. Brown directly beneficially owns 38,577.647 shares of Medifast common stock.
• Additionally, 4,232.967 shares are indirectly owned by the Jeffrey Brown Living Trust, for which Mr. Brown is the sole trustee and beneficiary.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive as it indicates a director increasing their stake in the company, aligning their interests with shareholders. However, it's primarily compensation-related rather than an open-market purchase, which typically carries stronger positive sentiment.

Positives

• The acquisition of shares by a director increases their beneficial ownership, aligning their interests more closely with those of shareholders.
• The use of restricted stock units and stock in lieu of cash compensation demonstrates a commitment to equity-based incentives for directors.

Future Outlook

The 11,167.542 restricted stock units acquired by Director Jeffrey J. Brown are scheduled to vest in full on June 25, 2026.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions, specifically related to director compensation. It reflects standard corporate governance practices where non-employee directors receive equity-based compensation, aligning their financial interests with the company's performance.

Related Party Transactions

• The acquisition of shares by Director Jeffrey J. Brown as part of his compensation falls under related party transactions, as it involves a transaction between the company and a member of its management/board.

Stakeholder Impact

• Shareholders: Increased director ownership can be viewed positively as it aligns management's interests with shareholder value creation.
• Employees: No direct impact mentioned.

Next Steps

• Vesting of the 11,167.542 restricted stock units on June 25, 2026.

Key Dates

Keywords

MEDIFAST, MED, Form 4, Insider Transaction, Director Compensation, Stock Acquisition, Restricted Stock Units, Deferred Compensation, Corporate Governance